TRex Bio, Inc. Common stock (TRXB)

TRex Bio, Inc. Common stock (TRXB) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $384M; returns 1 day -10.9%, 1 week -1.4%.

TRex Bio, Inc. (NASDAQ: TRXB) is a clinical-stage biopharmaceutical company focused on leveraging regulatory T-cell (Treg) biology in human tissue to discover and develop immunoregulatory medicines for autoimmune and inflammatory diseases.

Groups TRXB belongs to

• Recent IPOs
• Biotechnology
• Biopharmaceutical
• Clinical Stage Biotech
• Clinical Stage Biopharma
• Autoimmune Diseases
• Chronic Inflammatory Diseases
• Clinical Stage
• Immunotherapy
• Dermatology
• Drug Discovery

TRXB financial model: income statement, cash flow and balance sheet